equivalent incidence luvox and weight gain placebo-treated patients, were gastrointestinal complaints, including nausea (sometimes accompanied by vomiting), luvox and weight gain anorexia, diarrhea and luvox and weight gain CNS complaints, including somnolence, dry mouth, luvox and weight gain insomnia, dizziness, tremor and agitation; and asthenia. Abnormal (mostly delayed).

with fluvoxamine should be reconsidered.Dosage increases luvox and weight gain be made in 50 mg increments. Doses luvox and weight gain 150 mg should be divided so luvox and weight gain a maximum of 150 mg is given in the luvox and weight gain dose. Fluvoxamine should be swallowed with water and without chewing.Hepatic or luvox and weight gain Insufficiency:Patients with hepatic or luvox and weight gain insufficiency should begin treatment with a low dose and be carefully monitored.Children:The safety and effectiveness luvox and weight gain fluvoxamine in children under 18 years of age luvox and weight gain not been established.Adverse luvox and weight gain Observed:In clinical trials, the most commonly observed adverse luvox and weight gain luvox and weight gain with fluvoxamine administration, and not seen at an equivalent incidence among placebo-treated patients, luvox and weight gain gastrointestinal complaints, including nausea luvox and weight gain accompanied by vomiting), constipation, luvox and weight gain diarrhea and dyspepsia; CNS complaints, including somnolence, dry mouth, nervousness, insomnia, dizziness, tremor and agitation; and asthenia. Abnormal (mostly.

for abuse, tolerance and physical dependence luvox and weight gain fluvoxamine maleate has been studied in a nonhuman primate luvox and weight gain No evidence model.